This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove 2027 Remove Immunization Remove Pharmaceutical Companies Related Topics
Compounding Communication Vaccines FDA Pharmaceutical Companies More Related Topics >
article thumbnail

The future of targeted alpha therapy development and manufacture

European Pharmaceutical Review

MARCH 7, 2024

billion between 2022 to 2027. Lastly, there is growing prominence and interest in radioligand therapeutics within major pharmaceutical companies, who are increasingly investing in this field, evident through recent acquisitions of Point Biopharma and RayzeBio.

Pharmaceutical Companies 52
Pharmaceutical Companies Pharmaceutical Companies Immunization FDA 52
article thumbnail

High biologics demand spurs need for greater contract manufacturing

Pharmaceutical Technology

APRIL 24, 2023

. “Biologics products may contain proteins that control the action of other proteins and cellular processes, genes that control production of vital proteins, modified human hormones, or cells that produce substances that suppress or activate components of the immune system. Moreover, skilled manpower is required to run these facilities.

Vaccines 52
Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 18,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024